Vargas MV

Institute for Psychedelics and Neurotherapeutics, University of California, Davis, Davis, California 95616, United States.

8 papers · ORCID

ArticleMDMA

<i>R</i>-MDDMA is a Safer Analogue of MDMA with Therapeutic Potential.

Vargas MV, Hatzipantelis CJ, Dunlap LE +7

Europe PMC2026
ArticlePsilocybin

Disentangling the acute subjective effects of classic psychedelics from their enduring therapeutic properties.

Atiq MA, Baker MR, Voort JLV +2

Europe PMC2025
ArticlePsychedelics

Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors.

Vargas MV, Dunlap LE, Dong C +11

Europe PMC2023
ArticlePsilocybin

5-HT2ARs Mediate Therapeutic Behavioral Effects of Psychedelic Tryptamines.

Cameron LP, Patel SD, Vargas MV +6

Europe PMC2023
ArticlePsilocybin

Psychedelics and Other Psychoplastogens for Treating Mental Illness.

Vargas MV, Meyer R, Avanes AA +2

Europe PMC2021
ArticlePsychedelics

Psychedelic-inspired drug discovery using an engineered biosensor.

Dong C, Ly C, Dunlap LE +8

Europe PMC2021
ArticleIbogaine

A non-hallucinogenic psychedelic analogue with therapeutic potential.

Cameron LP, Tombari RJ, Lu J +26

Europe PMC2021
ArticleKetamine

Transient Stimulation with Psychoplastogens Is Sufficient to Initiate Neuronal Growth.

Ly C, Greb AC, Vargas MV +4

Europe PMC2021